Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis
Journal of the American Academy of Dermatology(2022)
摘要
Background
Microneedling as an adjuvant to topical medications has shown promising but variable results in the treatment of melasma.
Objective
To conduct a systematic review and meta-analysis on the efficacy of microneedling as an adjuvant to topical therapies for the treatment of melasma.
Methods
This study followed PRISMA guidelines. All comparative, prospective studies on the use of topical interventions with microneedling for the treatment of melasma were included. Studies involving radiofrequency microneedling were excluded.
Results
Twelve eligible studies comprising 459 patients from 7 different countries were included. Topical therapies included topical tranexamic acid, vitamin C, platelet-rich plasma, non-hydroquinone-based depigmentation serums, and hydroquinone-based depigmenting agents. Topical therapy with microneedling improved melasma severity with a large effect (standardized mean difference >0.8) beyond 8 weeks, with best results seen at 12 weeks. Compared to topical therapy alone, topical therapy with microneedling resulted in an additional improvement in melasma severity with a moderate effect at 8 weeks and a large effect at 12-16 weeks. Microneedling was well tolerated across studies, with no serious adverse events reported.
Limitations
Heterogeneity in study designs did not allow for a comparison of the efficacy of various topical therapies with microneedling.
Conclusion
Microneedling is useful adjuvant to topical therapies for the treatment of melasma.
更多查看译文
关键词
ascorbic acid,chemical peels,hydroquinone,laser,melasma,meta-analysis,microneedling,skin of color,systematic review,topical therapy,vitamin c,tranexamic acid
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要